Healthpeak Properties Inc (DOC)
Official siteREAL ESTATE • REIT - HEALTHCARE FACILITIES • NYSE
Market Cap: $13.23B
Last updated: Nov 17, 2026 at 4:40 PM ET
Healthpeak Properties Inc (DOC) Statistics
Healthpeak Properties (DOC) has a market cap of $13.23B and a P/FFO of 11.1x on its 2026 FFO estimate. Its return on invested capital of 0.70% compares with a 4.25% median across 12 similar companies. Its dividend yield is 6.15%.
Total Valuation
Enterprise value is 67.04% above the market cap, as debt exceeds cash.
| Market Cap | $13.23B |
|---|---|
| Enterprise Value | $22.10B |
| Latest price (Nov 17, 2026) | $19.84 |
Key Dates
The next earnings report is expected on Feb 1, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Dec 18, 2026.
| Next Earnings Date | Feb 1, 2027 (expected) |
|---|---|
| Last Earnings Date | Aug 4, 2026 |
| Next Ex-Dividend Date | Dec 18, 2026 |
| Next Payment Date | Dec 30, 2026 |
| Fiscal Year End | December |
Valuation Ratios
P/FFO is 11.1x on the 2026 FFO estimate of $1.79 a share. Its year-end P/S ranged from 4.4x to 41.9x from 2016 to 2025.
| P/FFO (2026 estimate) | 11.1x |
|---|---|
| P/E Ratio | 30.1x |
| Forward P/E | 55.3x |
| P/S Ratio | 5.0x |
| Forward P/S | 4.5x |
| P/B Ratio | 1.7x |
| P/TBV Ratio | 2.0x |
| P/FCF Ratio | 12.3x |
| P/OCF Ratio | 10.4x |
Enterprise Valuation
Counting debt and cash, the company is valued at 19.6x EBITDA and 20.3x free cash flow.
| EV / Earnings | 52.4x |
|---|---|
| EV / Sales | 8.1x |
| EV / EBITDA | 19.6x |
| EV / FCF | 20.3x |
Price Statistics
The stock is up 16.72% over 52 weeks and trades 1.74% above its 50-day average.
| Beta (1Y) | 0.36 |
|---|---|
| 52-Week Change | +16.72% |
| 1-Month Change | +5.64% |
| 3-Month Change | -1.41% |
| 6-Month Change | +3.79% |
| 5-Year Change | -46.41% |
| 10-Year Change | -44.44% |
| Total Return (1Y) | +23.90% |
| Total Return (3Y CAGR) | +10.61% |
| Total Return (5Y CAGR) | -6.71% |
| Return vs SPY (1Y) | +3.30% |
| Max Drawdown (1Y) | -18.12% |
| Max Drawdown (3Y) | -28.60% |
| Sharpe Ratio (1Y) | 0.49 |
| Correlation with SPY (1Y) | 0.17 |
| 50-Day Average | $19.50 |
| 200-Day Average | $18.90 |
| 52-Week Range | $14.96 to $22.72 |
| RSI (14 Days) | 53.9 |
| Average Volume (20 Days) | 6.10M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Total debt is 1.19x shareholder equity.
| Debt / Equity | 1.19x |
|---|---|
| Debt / EBITDA | 8.15x |
| Debt / FCF | 8.46x |
| Interest Coverage | 0.36x |
Returns and Efficiency
Return on invested capital is 0.70% over the last 12 months, against a 5-year average of 1.12%.
| Return on Equity (ROE) | 5.36% |
|---|---|
| Return on Assets (ROA) | 1.88% |
| Return on Invested Capital (ROIC) | 0.70% |
| ROE (5Y Average) | 5.13% |
| ROA (5Y Average) | 2.14% |
| ROIC (5Y Average) | 1.12% |
| Asset Turnover | 0.13x |
Taxes
Income tax took 1.49% of pretax income over the last 12 months.
| Income Tax (TTM) | $6.17M |
|---|---|
| Effective Tax Rate | 1.49% |
Scores
DOC has a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 4 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
FFO per share was $1.77 for 2025, the latest reported year. Revenue of $2.72B over the last 12 months is up 8.57% from the 12 months before.
| FFO Per Share (2025) | $1.77 |
|---|---|
| Revenue | $2.72B |
| Revenue Growth (YoY) | +8.57% |
| Pretax Income | $414.32M |
| Net Income | $421.38M |
| EBITDA | $1.15B |
| Reported EPS (TTM) | $0.66 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 35.12% of the $22.41B in total assets.
| Cash and Equivalents | $514.31M |
|---|---|
| Total Debt | $9.38B |
| Net Debt | $8.87B |
| Net Debt Per Share | $12.86 |
| Shareholder Equity | $7.87B |
| Book Value Per Share | $11.41 |
| Tangible Book Value | $6.88B |
| Tangible Book Per Share | $9.98 |
| Total Assets | $22.41B |
| Total Liabilities | $11.61B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $161.50M of capital spending, operating cash flow left $1.11B of free cash flow.
| Operating Cash Flow | $1.27B |
|---|---|
| Capital Expenditures | $161.50M |
| Free Cash Flow | $1.11B |
| FCF Per Share | $1.61 |
| Depreciation and Amortization | $1.24B |
| Dividends Paid | $844.40M |
| Share Repurchases | $101.75M |
Trailing 12 months through Sep 30, 2026.
Margins
| Pretax Margin | 15.23% |
|---|---|
| Net Margin | 15.49% |
| EBITDA Margin | 42.30% |
| FCF Margin | 40.76% |
| Gross Margin (5Y Average) | 57.00% |
| Operating Margin (5Y Average) | 20.29% |
| Net Margin (5Y Average) | 17.91% |
Growth
FFO per share grew 3.21% a year over 3 years, and revenue 10.06% a year.
| FFO Per Share Growth (3Y CAGR) | +3.21% |
|---|---|
| Revenue Growth (3Y CAGR) | +10.06% |
| Revenue Growth (5Y CAGR) | +12.03% |
| EPS Growth (3Y CAGR) | -51.00% |
| EPS Growth (5Y CAGR) | -35.20% |
| FCF Growth (3Y CAGR) | +12.19% |
| FCF Growth (5Y CAGR) | +10.97% |
| Operating Income Growth (3Y CAGR) | +15.13% |
| Book Value Per Share Growth (2Y CAGR) | -3.63% |
| Tangible Book Per Share Growth (2Y CAGR) | -6.04% |
Dividends and Yields
DOC pays out 68.93% of 2025 FFO as dividends.
| Dividend Per Share (Annual) | $1.22 |
|---|---|
| Dividend Yield | 6.15% |
| Payment Schedule | Monthly |
| Dividend Growth (3Y CAGR) | +6.86% |
| Dividend Growth (5Y CAGR) | -3.79% |
| Payout Ratio (2025 FFO) | 68.93% |
| FCF Payout Ratio | 76.14% |
| FFO Yield (2025) | 8.92% |
| FCF Yield | 8.11% |
| Buyback Yield | 0.73% |
| Shareholder Yield | 6.90% |
Stock Splits
The last split was a 2-for-1 forward split on Mar 2, 2004.
| Last Split Date | Mar 2, 2004 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 12 similar companies, DOC has the 10th highest P/FFO and the 10th highest P/S.
P/FFOPeer median 13.0x
P/S RatioPeer median 6.1x
ROICPeer median 4.25%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +21.75%
Dividend YieldPeer median 5.40%
| P/FFO | 11.1x vs 13.0x median |
|---|---|
| P/S Ratio | 5.0x vs 6.1x median |
| ROIC | 0.70% vs 4.25% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +8.57% vs +21.75% median |
| Dividend Yield | 6.15% vs 5.40% median |
Analyst Forecast
FFO per share estimates imply 2.23% growth a year over the next 2 years. Consensus estimates put revenue growth at 11.90% a year over the next 2 fiscal years.
| FFO Per Share Growth Forecast (2Y CAGR) | +2.23% |
|---|---|
| Revenue Growth Forecast (2Y CAGR) | +11.90% |
| EPS Growth Forecast (2Y CAGR) | +87.08% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About DOC
What is DOC's market cap?
Healthpeak Properties has a market cap of $13.23B. Its enterprise value, which adds debt and subtracts cash, is $22.10B.
What is DOC's P/E ratio?
Healthpeak Properties has a P/FFO of 11.1x on its 2026 FFO estimate. Its trailing P/E ratio is 30.1x and its forward P/E is 55.3x.
How many shares of DOC are outstanding?
Healthpeak Properties has 689.51M shares outstanding. The count is down 0.78% from a year earlier.
Does DOC pay a dividend?
Yes. Healthpeak Properties pays $1.22 a share a year, a dividend yield of 6.15%.
How much debt does DOC have?
Healthpeak Properties has $9.38B of total debt and $514.31M of cash and equivalents, a net debt position of $8.87B.
DOC pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors